Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.65 |
| ▸ | MAPT | P10636 | 5/20 | 0.65 |
| ▸ | DDX3X | O00571 | 2/20 | 0.65 |
| ▸ | POLB | P06746 | 2/20 | 0.65 |
| ▸ | HTT | P42858 | 2/20 | 0.65 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.65 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.55 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 3/20 | 0.54 |
| ▸ | RAB9A | P51151 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 2/20 | 0.52 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4816796 | 1.00 | MEN1 (0.65) | MEN1KMT2AMAPTDDX3XPOLB | |
| SCHEMBL17664266 | 0.87 | MEN1 (0.57) | MEN1KMT2AMAPTDDX3XPOLB | |
| SCHEMBL6129390 | 0.82 | MEN1 (0.90) | MEN1KMT2AMAPTDDX3XPOLB | |
| SCHEMBL6754380 | 0.82 | TRPV1 (0.73) | MEN1KMT2AMAPTPOLBHTT | |
| SCHEMBL6754378 | 0.82 | TRPV1 (0.73) | MEN1KMT2AMAPTPOLBHTT | |
| SCHEMBL23547197 | 0.82 | TRPV1 (0.73) | MEN1KMT2AMAPTPOLBHTT | |
| SCHEMBL27582580 | 0.81 | MEN1 (0.77) | MEN1KMT2AMAPTDDX3XPOLB | |
| SCHEMBL19398197 | 0.80 | ALDH1A1 (0.79) | MEN1KMT2AMAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL1047211 | 0.80 | MEN1 (1.00) | MEN1KMT2AMAPTDDX3XPOLB | |
| SCHEMBL27782782 | 0.80 | MEN1 (0.55) | MEN1KMT2AMAPTPOLBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2065365-A2 | Functional monomers for molecular recognition and catalysis | MIP Technologies AB (SE) | 2009-06-03 | — | — | EP | disclosed |
| EP-1927604-A1 | Functional monomers for molecular recognition and catalysis | MIP Technologies AB (SE) | 2008-06-04 | — | — | EP | disclosed |
| US-7332553-B2 | Functional monomers for molecular recognition and catalysis | MIP TECHNOLOGIES AB (SE) | 2008-02-19 | — | — | US | disclosed |
| US-20070106041-A1 | Functional monomers for molecular recognition and catalysis | MIP TECHNOLOGIES AB (SE) | 2007-05-10 | — | — | US | disclosed |
| US-7208557-B2 | Functional monomers for molecular recognition and catalysis | MIP TECHNOLOGIES AB (SE) | 2007-04-24 | — | — | US | disclosed |
| US-20050159570-A1 | Functional monomers for molecular recognition and catalysis | MIP TECHNOLOGIES AB, RESEARCH PARK IDEON (SE) | 2005-07-21 | — | — | US | disclosed |
| US-6870021-B2 | Functional monomers for molecular recognition and catalysis | MIP TECHNOLOGIES AB (SE) | 2005-03-22 | — | — | US | disclosed |
| US-20030166798-A1 | Functional monomers for molecular recognition and catalysis | MIP TECHNOLOGIES AB (SE) | 2003-09-04 | — | — | US | disclosed |
| EP-1250315-A1 | FUNCTIONAL MONOMERS FOR MOLECULAR RECOGNITION AND CATALYSIS | MIP Technologies AB (SE) | 2002-10-23 | — | — | EP | disclosed |
| WO-2001055095-A1 | FUNCTIONAL MONOMERS FOR MOLECULAR RECOGNITION AND CATALYSIS | MIP TECHNOLOGIES AB (SE) | 2001-08-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070106041-A1 | Functional monomers for molecular recognition and catalysis | PCNA, MUS81, PNMT | MEN1 2193/4885KMT2A 932/4885MAPT 2581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.